Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Enrico Bergamaschi is active.

Publication


Featured researches published by Enrico Bergamaschi.


Journal of Occupational and Environmental Medicine | 2012

A Road Map Toward a Globally Harmonized Approach for Occupational Health Surveillance and Epidemiology in Nanomaterial Workers.

Michael Riediker; Mary K. Schubauer-Berigan; Derk H. Brouwer; Inge Nelissen; Gudrun Koppen; Evelien Frijns; Katherine Clark; Juergen Hoeck; Saou-Hsing Liou; Sweet Far Ho; Enrico Bergamaschi; Rosemary Gibson

Objective: Few epidemiological studies have addressed the health of workers exposed to novel manufactured nanomaterials. The small current workforce will necessitate pooling international cohorts. Method: A road map was defined for a globally harmonized framework for the careful choice of materials, exposure characterization, identification of study populations, definition of health endpoints, evaluation of appropriateness of study designs, data collection and analysis, and interpretation of the results. Results: We propose a road map to reach global consensus on these issues. The proposed strategy should ensure that the costs of action are not disproportionate to the potential benefits and that the approach is pragmatic and practical. Conclusions: We should aim to go beyond the collection of health complaints, illness statistics, or even counts of deaths; the manifestation of such clear endpoints would indicate a failure of preventive measures.


Particle and Fibre Toxicology | 2017

The unrecognized occupational relevance of the interaction between engineered nanomaterials and the gastro-intestinal tract: a consensus paper from a multidisciplinary working group.

Antonio Pietroiusti; Enrico Bergamaschi; Marcello Campagna; Luisa Campagnolo; Giuseppe De Palma; Sergio Iavicoli; Veruscka Leso; Andrea Magrini; Michele Miragoli; Paola Pedata; Leonardo Palombi; Ivo Iavicoli

BackgroundThere is a fundamental gap of knowledge on the health effects caused by the interaction of engineered nanomaterials (ENM) with the gastro-intestinal tract (GIT). This is partly due to the incomplete knowledge of the complex physical and chemical transformations that ENM undergo in the GIT, and partly to the widespread belief that GIT health effects of ENM are much less relevant than pulmonary effects.However, recent experimental findings, considering the role of new players in gut physiology (e.g. the microbiota), shed light on several outcomes of the interaction ENM/GIT. Along with this new information, there is growing direct and indirect evidence that not only ingested ENM, but also inhaled ENM may impact on the GIT. This fact, which may have relevant implications in occupational setting, has never been taken into consideration.This review paper summarizes the opinions and findings of a multidisciplinary team of experts, focusing on two main aspects of the issue: 1) ENM interactions within the GIT and their possible consequences, and 2) relevance of gastro-intestinal effects of inhaled ENMs. Under point 1, we analyzed how luminal gut-constituents, including mucus, may influence the adherence of ENM to cell surfaces in a size-dependent manner, and how intestinal permeability may be affected by different physico-chemical characteristics of ENM. Cytotoxic, oxidative, genotoxic and inflammatory effects on different GIT cells, as well as effects on microbiota, are also discussed.Concerning point 2, recent studies highlight the relevance of gastro-intestinal handling of inhaled ENM, showing significant excretion with feces of inhaled ENM and supporting the hypothesis that GIT should be considered an important target of extrapulmonary effects of inhaled ENM.ConclusionsIn spite of recent insights on the relevance of the GIT as a target for toxic effects of nanoparticles, there is still a major gap in knowledge regarding the impact of the direct versus indirect oral exposure. This fact probably applies also to larger particles and dictates careful consideration in workers, who carry the highest risk of exposure to particulate matter.


Frontiers in Immunology | 2017

Lipopolysaccharide Adsorbed to the Bio-Corona of TiO2 Nanoparticles Powerfully Activates Selected Pro-inflammatory Transduction Pathways

Massimiliano G. Bianchi; Manfredi Allegri; Martina Chiu; Anna Luisa Costa; Magda Blosi; Simona Ortelli; Ovidio Bussolati; Enrico Bergamaschi

It is known that the adsorption of bioactive molecules provides engineered nanoparticles (NPs) with novel biological activities. However, the biological effects of the adsorbed molecules may also be modified by the interaction with NP. Bacterial lipopolysaccharide (LPS), a powerful pro-inflammatory compound, is a common environmental contaminant and is present in several body compartments such as the gut. We recently observed that the co-incubation of LPS with TiO2 NPs markedly potentiates its pro-inflammatory effects on murine macrophages, suggesting that, when included in a NP bio-corona, LPS activity is enhanced. To distinguish the effects of adsorbed LPS from those of the free endotoxin, a pellet fraction, denominated P25/LPS, was isolated by centrifugation from a mixture of P25 TiO2 NP (128u2009µg/ml) and LPS (10u2009ng/ml) in the presence of fetal bovine serum. Western blot analysis of the pellet eluate indicated that the P25/LPS fraction contained, besides proteins, also LPS, pointing to the presence of LPS-doped NP. The effects of adsorbed or free LPS were then compared in Raw264.7 murine macrophages. RT-PCR was used to evaluate the induction of cytokine genes, whereas active, phosphorylated isoforms of proteins involved in signaling pathways were assessed with western blot. At a nominal LPS concentration of 40u2009pg/ml, P25/LPS induced the expression of both NF-κB and IRF3-dependent cytokines at levels comparable with those observed with free LPS (10u2009ng/ml), although with different time courses. Moreover, compared to free LPS, P25/LPS caused a more sustained phosphorylation of p38 MAPK and a more prolonged induction of STAT1-dependent genes. Cytochalasin B partially inhibited the induction of Tnfa by P25/LPS, but not by free LPS, and suppressed the induction of IRF3-dependent genes by either P25/LPS or free LPS. These data suggest that, when included in the bio-corona of TiO2 NP, LPS exhibits enhanced and time-shifted pro-inflammatory effects. Thus, in assessing the hazard of NP in real life, the enhanced effects of adsorbed bioactive molecules should be taken into account.


Risk Analysis | 2018

The Essential Elements of a Risk Governance Framework for Current and Future Nanotechnologies

Vicki Stone; Martin Führ; Peter H. Feindt; Hans Bouwmeester; Igor Linkov; Stefania Sabella; Finbarr Murphy; Kilian Bizer; Lang Tran; Marlene Ågerstrand; Carlos Fito; Torben Juul Andersen; Diana Anderson; Enrico Bergamaschi; John W. Cherrie; Sue Cowan; Jean-Francois Dalemcourt; Michael Faure; Silke Gabbert; Agnieszka Gajewicz; Teresa F. Fernandes; Danail Hristozov; Helinor Johnston; Terry C. Lansdown; Stefan Linder; Hans J.P. Marvin; Martin Mullins; Kai P. Purnhagen; Tomasz Puzyn; Araceli Sánchez Jiménez

Societies worldwide are investing considerable resources into the safe development and use of nanomaterials. Although each of these protective efforts is crucial for governing the risks of nanomaterials, they are insufficient in isolation. What is missing is a more integrative governance approach that goes beyond legislation. Development of this approach must be evidence based and involve key stakeholders to ensure acceptance by end users. The challenge is to develop a framework that coordinates the variety of actors involved in nanotechnology and civil society to facilitate consideration of the complex issues that occur in this rapidly evolving research and development area. Here, we propose three sets of essential elements required to generate an effective risk governance framework for nanomaterials. (1) Advanced tools to facilitate risk-based decision making, including an assessment of the needs of users regarding risk assessment, mitigation, and transfer. (2) An integrated model of predicted human behavior and decision making concerning nanomaterial risks. (3) Legal and other (nano-specific and general) regulatory requirements to ensure compliance and to stimulate proactive approaches to safety. The implementation of such an approach should facilitate and motivate good practice for the various stakeholders to allow the safe and sustainable future development of nanotechnology.


Journal of Epidemiology and Community Health | 2018

Methodological, political and legal issues in the assessment of the effects of nanotechnology on human health

Irina Guseva Canu; Paul A. Schulte; Michael Riediker; Liliya M. Fatkhutdinova; Enrico Bergamaschi

Engineered nanomaterials (ENMs) raise questions among the scientific community and public health authorities about their potential risks to human health. Studying a prospective cohort of workers exposed to ENMs would be considered the gold standard for identifying potential health effects of nanotechnology and confirming the ‘no effect’ levels derived from cellular and animal models. However, because only small, cross-sectional studies have been conducted in the past 5 years, questions remain about the health risks of ENMs. This essay addresses the scientific, methodological, political and regulatory issues that make epidemiological research in nanotechnology-exposed communities particularly complex. Scientific challenges include the array of physicochemical parameters and ENM production conditions, the lack of universally accepted definitions of ENMs and nanotechnology workers, and the lack of information about modes of action, target organs and likely dose–response functions of ENMs. Standardisation of data collection and harmonisation of research protocols are needed to eliminate misclassification of exposures and health effects. Forming ENM worker cohorts from a combination of smaller cohorts and overcoming selection bias are also challenges. National or international registries for monitoring the exposures and health of ENM workers would be helpful for epidemiological studies, but the creation of such a registry and ENM worker cohorts will require political support and dedicated funding at the national and international levels. Public authorities and health agencies should consider carrying out an ENM awareness campaign to educate and engage all stakeholders and concerned communities in discussion of such a project.


Adverse Effects of Engineered Nanomaterials (Second Edition)#R##N#Exposure, Toxicology, and Impact on Human Health | 2017

Chapter 6 – Biomonitoring

Enrico Bergamaschi; Irina Guseva Canu; Adriele Prina-Mello; Andrea Magrini

Biological monitoring has the potential to decrease the uncertainty in estimating exposures by conventional methods, to provide biologically relevant measures of exposure, and to determine whether individuals or a population are at increased risk of adverse health effects caused by specific chemicals. Recent developments in system toxicology and “omics” techniques have provided many promising biological markers to assess both local and systemic changes following nanomaterial exposure. In biomarker development, a pragmatic approach is to draw exploratory and candidate biomarkers from other fields of particle and metal toxicology. Since biological monitoring has a different meaning in research and in practice, candidate biomarkers, which are potentially useful for occupational health surveillance, epidemiology and environmental sustainability should meet validity criteria, and thus undergo field validation and assessment of their predictive value toward relevant health outcomes and, ultimately, potential risks associated with nanomaterials. Moreover, biomarkers based on noninvasive methods deserve particular consideration in human biological monitoring.


Archive | 2017

Research priorities relevant to development or updating of nano-relevant regulations and guidelines

Vicki Stone; Serli Önlü; Enrico Bergamaschi; David Carlander; Anna Luisa Costa; Wilson Engelmann; Antoine Ghanem; Sonja Hartl; Danail Hristozov; Janeck J. Scott-Fordsmand; Keld A. Jensen; Frank von der Kammer; Jacques-Aurelien Sergent; Monita Sharma; Maria Dusinska; Bernd Nowack; Phil Sayre; Ulla Vogel; Martie van Tongeren; Socorro Vázquez-Campos; Wendel Wohlleben


Inhaled Particles XI | 2013

Structural Alerts of Particle Toxicity: Looking to the past to predict the future

Craig A. Poland; Julia Varet; Steve Hankin; Lucia Migliore; Bucchianico Sebastiano Di; Ovidio Bussolati; Enrico Bergamaschi


2nd QNano Integrating Conference “Quality in nanosafety assessment – driving best practice and innovation" | 2013

A preliminary study of engineered nanoparticles effects on barrier function of airway epithelial monolayers

Di Cristo Luisana; Rotoli Bianca Maria; Elisabetta Barocelli; Ovidio Bussolati; Enrico Bergamaschi


Archive | 2009

A toxicological approach to hazard assessment of carbon nanotubes: implications for workers' health

Enrico Bergamaschi; Ivo Iavicoli; Ovidio Bussolati

Collaboration


Dive into the Enrico Bergamaschi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Vicki Stone

Heriot-Watt University

View shared research outputs
Top Co-Authors

Avatar

A. Mutti

Istituto Giannina Gaslini

View shared research outputs
Top Co-Authors

Avatar

Andrea Magrini

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

Danail Hristozov

Ca' Foscari University of Venice

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ivo Iavicoli

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge